Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Insight into structural diversity of influenza virus haemagglutinin.

Cho KJ, Lee JH, Hong KW, Kim SH, Park Y, Lee JY, Kang S, Kim S, Yang JH, Kim EK, Seok JH, Unzai S, Park SY, Saelens X, Kim CJ, Lee JY, Kang C, Oh HB, Chung MS, Kim KH.

J Gen Virol. 2013 Aug;94(Pt 8):1712-22. doi: 10.1099/vir.0.051136-0. Epub 2013 May 1.

PMID:
23636824
2.

Conserved neutralizing epitope at globular head of hemagglutinin in H3N2 influenza viruses.

Iba Y, Fujii Y, Ohshima N, Sumida T, Kubota-Koketsu R, Ikeda M, Wakiyama M, Shirouzu M, Okada J, Okuno Y, Kurosawa Y, Yokoyama S.

J Virol. 2014 Jul;88(13):7130-44. doi: 10.1128/JVI.00420-14. Epub 2014 Apr 9.

3.

Antigen distortion allows influenza virus to escape neutralization.

Fleury D, Wharton SA, Skehel JJ, Knossow M, Bizebard T.

Nat Struct Biol. 1998 Feb;5(2):119-23.

PMID:
9461077
4.

Structure of influenza virus haemagglutinin complexed with a neutralizing antibody.

Bizebard T, Gigant B, Rigolet P, Rasmussen B, Diat O, Bösecke P, Wharton SA, Skehel JJ, Knossow M.

Nature. 1995 Jul 6;376(6535):92-4.

PMID:
7596443
5.

An antibody against a novel and conserved epitope in the hemagglutinin 1 subunit neutralizes numerous H5N1 influenza viruses.

Oh HL, Akerström S, Shen S, Bereczky S, Karlberg H, Klingström J, Lal SK, Mirazimi A, Tan YJ.

J Virol. 2010 Aug;84(16):8275-86. doi: 10.1128/JVI.02593-09. Epub 2010 Jun 2.

6.

Monoclonal antibodies to glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin.

Russ G, Poláková K, Kostolanský F, Styk B, Vancíková M.

Acta Virol. 1987 Sep;31(5):374-86.

PMID:
2891276
7.

An antibody which binds to the membrane-proximal end of influenza virus haemagglutinin (H3 subtype) inhibits the low-pH-induced conformational change and cell-cell fusion but does not neutralize virus.

Vanlandschoot P, Beirnaert E, Barrère B, Calder L, Millar B, Wharton S, Jou WM, Fiers W.

J Gen Virol. 1998 Jul;79 ( Pt 7):1781-91.

PMID:
9680143
8.

Fully human broadly neutralizing monoclonal antibodies against influenza A viruses generated from the memory B cells of a 2009 pandemic H1N1 influenza vaccine recipient.

Hu W, Chen A, Miao Y, Xia S, Ling Z, Xu K, Wang T, Xu Y, Cui J, Wu H, Hu G, Tian L, Wang L, Shu Y, Ma X, Xu B, Zhang J, Lin X, Bian C, Sun B.

Virology. 2013 Jan 20;435(2):320-8. doi: 10.1016/j.virol.2012.09.034. Epub 2012 Oct 16.

9.

Reverse engineering the antigenic architecture of the haemagglutinin from influenza H5N1 clade 1 and 2.2 viruses with fine epitope mapping using monoclonal antibodies.

Rockman S, Camuglia S, Vandenberg K, Ong C, Baker MA, Nation RL, Li J, Velkov T.

Mol Immunol. 2013 Apr;53(4):435-42. doi: 10.1016/j.molimm.2012.10.001. Epub 2012 Nov 3.

PMID:
23127859
10.

Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin.

Skehel JJ, Wiley DC.

Annu Rev Biochem. 2000;69:531-69. Review.

PMID:
10966468
11.

Insight into highly conserved H1 subtype-specific epitopes in influenza virus hemagglutinin.

Cho KJ, Hong KW, Kim SH, Seok JH, Kim S, Lee JH, Saelens X, Kim KH.

PLoS One. 2014 Feb 26;9(2):e89803. doi: 10.1371/journal.pone.0089803. eCollection 2014.

12.

An antibody that prevents the hemagglutinin low pH fusogenic transition.

Barbey-Martin C, Gigant B, Bizebard T, Calder LJ, Wharton SA, Skehel JJ, Knossow M.

Virology. 2002 Mar 1;294(1):70-4.

13.

Development and characterization of neutralizing monoclonal antibodies against the pandemic H1N1 virus (2009).

Cabral TM, Berhane Y, Schmidt L, Tracz DM, Hole K, Leith M, Corbett CR.

J Virol Methods. 2012 Jul;183(1):25-33. doi: 10.1016/j.jviromet.2012.03.016. Epub 2012 Apr 4.

PMID:
22575685
14.

A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site.

Fleury D, Barrère B, Bizebard T, Daniels RS, Skehel JJ, Knossow M.

Nat Struct Biol. 1999 Jun;6(6):530-4.

PMID:
10360354
15.
16.

Inhibition of fusion activity of influenza A haemagglutinin mediated by HA2-specific monoclonal antibodies.

Varecková E, Mucha V, Wharton SA, Kostolanský F.

Arch Virol. 2003 Mar;148(3):469-86.

PMID:
12607099
17.

Energetics of the loop-to-helix transition leading to the coiled-coil structure of influenza virus hemagglutinin HA2 subunits.

Huang Q, Korte T, Rachakonda PS, Knapp EW, Herrmann A.

Proteins. 2009 Feb 1;74(2):291-303. doi: 10.1002/prot.22157.

PMID:
18618705
18.

Isolation of a high affinity neutralizing monoclonal antibody against 2009 pandemic H1N1 virus that binds at the 'Sa' antigenic site.

Shembekar N, Mallajosyula VV, Mishra A, Yeolekar L, Dhere R, Kapre S, Varadarajan R, Gupta SK.

PLoS One. 2013;8(1):e55516. doi: 10.1371/journal.pone.0055516. Epub 2013 Jan 31.

19.

Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner.

Mullarkey CE, Bailey MJ, Golubeva DA, Tan GS, Nachbagauer R, He W, Novakowski KE, Bowdish DM, Miller MS, Palese P.

MBio. 2016 Oct 4;7(5). pii: e01624-16. doi: 10.1128/mBio.01624-16.

20.

The epitope and neutralization mechanism of AVFluIgG01, a broad-reactive human monoclonal antibody against H5N1 influenza virus.

Cao Z, Meng J, Li X, Wu R, Huang Y, He Y.

PLoS One. 2012;7(5):e38126. doi: 10.1371/journal.pone.0038126. Epub 2012 May 25.

Supplemental Content

Support Center